Neurocrine Biosciences (NBIX) Common Stock Issued (2010 - 2026)
Neurocrine Biosciences (NBIX) reported Common Stock Issued of $25.3 million for Q3 2026, down 44.5% from $45.6 million a year earlier and down 70.2% from the prior quarter.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Common Stock Issued (2010 - 2026) Analysis & Trends
Over the twelve months ended Sep 30, 2026, Neurocrine Biosciences' Common Stock Issued came in at $171 million, up 67.5% year-over-year; for FY2025, it was $129.4 million, up 6.0% from FY2024.
- Common Stock Issued has increased for four consecutive years, with a five-year compound annual growth rate of 34.8% (FY2020 to FY2025).
- By year, Common Stock Issued came in at $122.1 million in FY2024 (+87.0%), $65.3 million in FY2023 (+46.1%), $44.7 million in FY2022 (+62.5%) and $27.5 million in FY2021 (-5.5%).
- Five-year quarterly Common Stock Issued spans a low of $1.8 million in Q4 2021 and a high of $84.8 million in Q2 2026.
- Year over year, Common Stock Issued gained in three of the last eight quarters, with growth averaging 78.6%.
- The high point for year-over-year Common Stock Issued in five years was Q1 2024 (growth of 752.4%); the low point was Q4 2024 (a decline of 71.8%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $84.8 million (Q2 2026), $23.6 million (Q1 2026) and $37.3 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 743.00 Mn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 247.00 Mn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 4.00 Mn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 87.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Neurocrine Biosciences | 17.13 Bn | 13.21 Bn | 1.10 Bn | 25.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 25.30 Mn |
| Jun 30, 2026 | 84.80 Mn |
| Mar 31, 2026 | 23.60 Mn |
| Dec 31, 2025 | 37.30 Mn |
| Sep 30, 2025 | 45.60 Mn |
| Jun 30, 2025 | 14.40 Mn |
| Mar 31, 2025 | 32.10 Mn |
| Dec 31, 2024 | 10.00 Mn |
| Sep 30, 2024 | 26.40 Mn |
| Jun 30, 2024 | 15.80 Mn |
| Mar 31, 2024 | 69.90 Mn |
| Dec 31, 2023 | 35.40 Mn |
| Sep 30, 2023 | 18.80 Mn |
| Jun 30, 2023 | 2.90 Mn |
| Mar 31, 2023 | 8.20 Mn |
| Dec 31, 2022 | 24.60 Mn |
| Sep 30, 2022 | 11.40 Mn |
| Jun 30, 2022 | 2.60 Mn |
| Mar 31, 2022 | 6.10 Mn |
| Dec 31, 2021 | 1.80 Mn |
API Access
Neurocrine Biosciences Common Stock Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-stock-issued&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-stock-issued", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-stock-issued&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();